Real-time enrollment status for this chronic migraine clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 4:15 AM UTC
| NCT Number | NCT07018713 |
| Recruiting Status | Recruiting |
| Condition | Chronic Migraine |
| Phase | PHASE3 |
| Target Enrollment | 780 participants |
| Active Locations | 47 sites in the US |
| Sponsor | Merz Therapeutics GmbH |
| Last Updated on CT.gov | June 25, 2026 (3 weeks ago) |
As of July 19, 2026: Clinical trial NCT07018713 is currently recruiting participants. This phase3 study for chronic migraine is actively seeking new participants at 47 locations across the United States. The study is sponsored by Merz Therapeutics GmbH. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07018713 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 47 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07018713 was last updated 3 weeks ago (June 25, 2026). HelloStudys verifies this status automatically.